Günter Fingerle-Rowson - Veröffentlichungen allgemein

(1 - 6 von 6

)

A Review of Obinutuzumab (GA101), a Novel Type II Anti- ...Springer

link.springer.com

von K Tobinai · · Zitiert von: 168 — Günter Fingerle-Rowson is an employee at F. Hoffmann-La Roche Ltd. and owns stock in F. Hoffmann-La Roche Ltd. Compliance with Ethics ... von K Tobinai · · Zitiert von: 168 — Günter Fingerle-Rowson is an employee at F. Hoffmann-La Roche Ltd. and owns stock in F. Hoffmann-La Roche Ltd. Compliance with Ethics ...

Expansion of CD14+CD16+Monocytes in Critically Ill ...Springer

link.springer.com

von G Fingerle-Rowson · · Zitiert von: 109 — Authors and Affiliations. Department of Internal Medicine I, Klinikum Grosshadern, University of Muenchen, Muenchen, FRG. Günter Fingerle-Rowson & Jens Auers. von G Fingerle-Rowson · · Zitiert von: 109 — Authors and Affiliations. Department of Internal Medicine I, Klinikum Grosshadern, University of Muenchen, Muenchen, FRG. Günter Fingerle-Rowson & Jens Auers.

Verwandte Suchanfragen zu Günter Fingerle-Rowson

Marcel Wolbers
Michael Kneba
Philipp Lacher

Georg Lenz
Suada Fröhlich
Dominik Schumacher

Kaspar Rufibach
Jörg Klug
Andreas Meinhardt

Personen
Vorname "Günter" (29119)
Name

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Veröffentlichungen allgemein Günter Fingerle-Rowson

A Review of Obinutuzumab (GA101), a Novel Type II Anti- ...Springer

Expansion of CD14+CD16+Monocytes in Critically Ill ...Springer

Table of Contents | International Journal of Cell Biologywww.hindawi.com › journals › ijcb › contents › year

Günter Fingerle-Rowson Selected ResearchCureHunter

Günter Fingerle-Rowson - Wikidatawww.wikidata.org › wiki

(PDF) Prognostic Impact of Somatic Mutations in DiffuseAmanote